Table 3.
Adjusted ORs (95% CI) of MetS and its components according to the quartiles of MUAC
| ORs (95% CI) | P value for trend |
||||
|---|---|---|---|---|---|
| Q1 | Q2 | Q3 | Q4 | ||
| MetS | |||||
| Model 1a | 1.00 | 1.79 (1.60–2.02) | 3.28 (2.91–3.70) | 5.77 (5.08–6.54) | < 0.001 |
| Model 2b | 1.00 | 1.77 (1.56–2.01) | 3.25 (2.85–3.70) | 5.71 (4.97–6.56) | < 0.001 |
| Model 3c | 1.00 | 1.55 (1.35–1.78) | 2.49 (2.17–2.86) | 3.24 (2.79–3.76) | < 0.001 |
| Model 4d | 1.00 | 1.23 (1.07–1.42) | 1.68 (1.45–1.95) | 1.77 (1.51–2.09) | < 0.001 |
| Central obesity | |||||
| Model 1a | 1.00 | 2.50 (2.22–2.81) | 5.67 (5.00–6.43) | 15.31 (13.17–17.81) | < 0.001 |
| Model 2b | 1.00 | 2.47 (2.18–2.81) | 5.52 (4.82–6.31) | 14.70 (12.49–17.31) | < 0.001 |
| Model 3c | 1.00 | 2.29 (2.00–2.61) | 4.69 (4.08–5.40) | 10.57 (8.93–12.52) | < 0.001 |
| Model 4d | 1.00 | 1.41 (1.20–1.65) | 2.03 (1.71–2.40) | 3.46 (2.81–4.25) | < 0.001 |
| Elevated blood pressure | |||||
| Model 1a | 1.00 | 1.27 (1.13–1.43) | 1.66 (1.48–1.87) | 2.15 (1.91–2.42) | < 0.001 |
| Model 2b | 1.00 | 1.26 (1.11–1.43) | 1.64 (1.45–1.86) | 2.11 (1.86–2.40) | < 0.001 |
| Model 3c | 1.00 | 1.18 (1.03–1.34) | 1.45 (1.27–1.65) | 1.65 (1.44–1.88) | < 0.001 |
| Model 4d | 1.00 | 1.04 (0.91–1.18) | 1.16 (1.02–1.33) | 1.17 (1.01–1.35) | < 0.001 |
| Elevated triglycerides | |||||
| Model 1a | 1.00 | 1.44 (1.23–1.69) | 1.81 (1.55–2.11) | 2.34 (2.02–2.72) | < 0.001 |
| Model 2b | 1.00 | 1.39 (1.17–1.65) | 1.81 (1.54–2.14) | 2.23 (1.90–2.62) | < 0.001 |
| Model 3c | 1.00 | 1.26 (1.06–1.50) | 1.49 (1.26–1.77) | 1.52 (1.28–1.80) | < 0.001 |
| Model 4d | 1.00 | 1.21 (1.02–1.45) | 1.36 (1.14–1.64) | 1.40 (1.17–1.67) | < 0.001 |
| Reduced HDL cholesterol | |||||
| Model 1a | 1.00 | 1.45 (1.27–1.66) | 1.70 (1.49–1.93) | 2.18 (1.91–2.48) | < 0.001 |
| Model 2b | 1.00 | 1.36 (1.18–1.58) | 1.68 (1.45–1.94) | 2.06 (1.79–2.37) | < 0.001 |
| Model 3c | 1.00 | 1.29 (1.11–1.50) | 1.50 (1.30–1.74) | 1.68 (1.45–1.95) | < 0.001 |
| Model 4d | 1.00 | 1.23 (1.06–1.43) | 1.38 (1.19–1.61) | 1.46 (1.24–1.71) | < 0.001 |
| Elevated fasting glucose | |||||
| Model 1a | 1.00 | 1.28 (1.13–1.45) | 1.48 (1.32–1.72) | 1.51 (1.33–1.73) | < 0.001 |
| Model 2b | 1.00 | 1.28 (1.12–1.47) | 1.51 (1.04–1.34) | 1.54 (1.35–1.76) | < 0.001 |
| Model 3c | 1.00 | 1.23 (1.08–1.41) | 1.41 (1.23–1.61) | 1.38 (1.20–1.57) | < 0.001 |
| Model 4d | 1.00 | 1.14 (0.99–1.32) | 1.15 (1.00–1.32) | 1.25 (1.09–1.44) | < 0.001 |
a Model 1 was adjusted for age and gender. b Model 2 was further adjusted for smoking, alcohol drinking, educational attainment, physical activity, and self-reported CVD. c Model 3 was further adjusted for CRP, adiponectin, and HOMA-IR. d Model 4 was further adjusted for BMI. Q, quartile. Q1 is the reference group. Multivariate logistic regression models were used to estimate the odds ratios (ORs) with corresponding 95% confidence intervals (CIs) for MetS and its components. The final model is statistically significant (χ2 = 34.927, P < 0.001)